22 May 2019 — The ECHO Consortium is pleased to announce that the primary analysis of data from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial has been completed. ECHO is a randomised clinical trial, conducted among 7,830 women at 12 sites across Eswatini, Kenya, South Africa and Zambia, designed to provide high-quality evidence about the potential association between certain contraceptives and the risk of HIV acquisition. A draft manuscript describing the results has been submitted to a journal and is under peer review. Download PDF.

ECHO update_ final_22MAY2019
ECHO Study Update, 22 May 2019